PALATIN TECHNOLOGIES, INC. Deferred Income Tax Expense (Benefit)
PALATIN TECHNOLOGIES, INC. (PTN) reported Deferred Income Tax Expense (Benefit) of $0 for the 12-month period ending 2020-06-30, per its 10-K filed 2020-09-25.
Discontinued › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2020-09-25
- PALATIN TECHNOLOGIES, INC. deferred income tax expense (benefit) for the quarter ending 2019-06-30 was $0.00.
- PALATIN TECHNOLOGIES, INC. deferred income tax expense (benefit) for the quarter ending 2019-03-31 was $0.00.
- PALATIN TECHNOLOGIES, INC. deferred income tax expense (benefit) for the quarter ending 2018-06-30 was $0.00.
- PALATIN TECHNOLOGIES, INC. deferred income tax expense (benefit) for the quarter ending 2018-03-31 was $0.00.
- PALATIN TECHNOLOGIES, INC. deferred income tax expense (benefit) for fiscal 2020 was $0.00.
- PALATIN TECHNOLOGIES, INC. deferred income tax expense (benefit) for fiscal 2019 was $0.00.
- PALATIN TECHNOLOGIES, INC. deferred income tax expense (benefit) for fiscal 2018 was -$500.00K.
- PALATIN TECHNOLOGIES, INC. deferred income tax expense (benefit) for fiscal 2017 was $0.00.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2020-06-30 | $0.00 10-K · filed 2020-09-25 | |||
| 2019-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-25 | $0.00 derived: sum of 2 quarters · filed 2020-09-25 | $0.00 10-K · filed 2020-09-25 | |
| 2019-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-09 | $0.00 10-Q · filed 2019-05-09 | ||
| 2018-12-31 | $0.00 10-Q · filed 2019-02-11 | |||
| 2018-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-25 | $0.00 derived: sum of 2 quarters · filed 2020-09-25 | -$500.00K 10-K · filed 2020-09-25 | |
| 2018-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-09 | -$500.00K 10-Q · filed 2019-05-09 | ||
| 2017-12-31 | -$500.00K 10-Q · filed 2019-02-11 | |||
| 2017-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-12 | $0.00 derived: sum of 2 quarters · filed 2019-09-12 | $0.00 10-K · filed 2019-09-12 | |
| 2017-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-14 | $0.00 10-Q · filed 2018-05-14 | ||
| 2016-12-31 | $0.00 10-Q · filed 2018-02-12 | |||
| 2016-06-30 | $0.00 10-K · filed 2018-09-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |